Concepedia

Rachel M.A. Linger

RM

Statistics

Publications

6

Citations

586

H-Index

6

Active since

2008

Affiliations

University of Colorado Anschutz Medical Campus(Current)

University of Colorado Denver

University of North Carolina at Chapel Hill

UNC Lineberger Comprehensive Cancer Center

Rachel M.A. Linger is an author at University of Colorado Anschutz Medical Campus specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2008–2014

6

Publications

6

Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer

Rachel M.A. Linger, Richard A. Cohen, Christopher T. Cummings et al. · Oncogene · 2012 · 215 citations · Full text

, , +10

Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices

Susan Goebel-Goody, Kurtis D. Davies, Rachel M.A. Linger et al. · Neuroscience · 2008 · 188 citations

, , +8

Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia

Rachel M.A. Linger, Alisa B. Lee‐Sherick, Deborah DeRyckere et al. · Blood · 2013 · 62 citations · Full text

Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer

Christopher T. Cummings, Rachel M.A. Linger, Rebecca A. Cohen et al. · Oncotarget · 2014 · 54 citations · Full text

Prolonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the Nucleus

Justine Migdall-Wilson, C Ryan Bates, Jennifer Schlegel et al. · PLoS ONE · 2012 · 37 citations · Full text

, , +19

Rows per page

1–5 of 6